Thieker, David F. http://orcid.org/0000-0003-0786-8278
Xu, Yongmei
Chapla, Digantkumar
Nora, Chelsea
Qiu, Hong
Felix, Thomas
Wang, Lianchun http://orcid.org/0000-0003-1454-2719
Moremen, Kelley W. http://orcid.org/0000-0003-1768-582X
Liu, Jian
Esko, Jeffrey D. http://orcid.org/0000-0001-8322-1834
Woods, Robert J.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA207824, CA207824, CA207824)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM103390, GM107012, GM33063, GM103390, GM107012, GM33063)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL093339, HL093339)
Article History
Received: 3 May 2018
Accepted: 9 July 2018
First Online: 7 August 2018
Change Date: 9 June 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing Interests
: J. L. is a founder of Glycan Therapeutics. D.F.T., Y.X., D.K., C.N., T.F., H.Q., L.W., K.W.M., J.D.E., and R.J.W. declare no competing interests.